Editorial / About this project
About Rx MOTS-c
An independent editorial project that lays out the MOTS-c research record as a curated specimen catalogue — and is honest about where the human evidence stops.
What this site is
Rx MOTS-c is an independent editorial project that publishes summaries of the peer-reviewed research literature on MOTS-c. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site treats the MOTS-c literature the way a catalogue treats specimens: each study, dose figure, mechanism, and regulatory fact is set out as its own labelled entry, cited to source, with equal weight given to what the research establishes and to what it does not. A confirmed preclinical finding and an honest "no human interventional data" note sit side by side, by design.
What the name means
The "Rx" in Rx MOTS-c is editorial framing, not a service claim. It signals that this digest pays close attention to the medicinal and regulatory questions readers actually have — the FDA status, the 503A compounding framework, the anti-doping rules — and lays them out plainly. It does not mean the site prescribes, dispenses, or supplies anything. There is no pharmacy here, no prescriber, and no product.
We name no vendors, clinics, or telehealth providers. Where the regulatory landscape is genuinely in motion — as with the FDA Pharmacy Compounding Advisory Committee's scheduled July 2026 evaluation of MOTS-c — we describe it as exactly what it is: a scheduled discussion, not a decision.
How we handle evidence
Every quantitative claim on this site is tied to a specific published study, listed on the references page with its DOI and PubMed identifier. We distinguish animal and cell findings from human data, and we distinguish observational human biomarker associations from interventional trials — a distinction that matters a great deal for MOTS-c, where the animal evidence is substantial and the human interventional evidence does not yet exist.
We favour the language of the studies themselves: doses are reported as administered to a species by a route, never as recommendations. When the literature is silent, we say so rather than fill the gap. The goal is a record a careful reader can trust and verify against the primary sources.